NCT00423943View on ClinicalTrials.gov

Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

modafinil

200 milligrams daily dose

DRUG

Placebos

capsule containing placebo

Trial Locations (1)

90095

University of California Los Angeles School of Medicine, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT00423943 - Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia | Biotech Hunter | Biotech Hunter